Acquiring Company
GTCR
Acquired Company
Surmodics
ChicagoEden PrairieFinancial ServicesFinanceVenture CapitalAngel InvestmentManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Surmodics, Inc. has announced that it will not host a live webcast for its Q2 2025 financial results due to a pending acquisition by GTCR. The financial results will be released on April 30, 2025. Surmodics specializes in medical device technologies aimed at improving health care outcomes.
Quick answer
GTCR is acquiring Surmodics, announced April 28, 2025. GTCR is based in Chicago, Illinois, United States.
- How much did GTCR pay for Surmodics?
- The deal value was not disclosed.
- What does GTCR do?
- GTCR is a leading private equity firm focused on investing in growth and could manage companies.
- Where are GTCR and Surmodics based?
- GTCR is based in Chicago, Illinois, United States. Surmodics is based in Eden Prairie, Minnesota, United States.
- Who are the decision-makers at GTCR?
- Fundz holds 1 contact at GTCR. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Finance
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- KKR to acquire Topcon for medical gear expansion (March 27, 2025)
- VERAXA Biotech merges with Voyager Acquisition Corp (April 22, 2025)
- AbbVie to acquire Cerevel Therapeutics for $45 per share (May 28, 2025)
- Merit Medical acquires BioLife hemostasis products (May 21, 2025)
- KKR acquires OTC solutions provider OSTTRA (April 30, 2025)
Who to call at GTCR, and when
When GTCR changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day GTCR raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GTCR, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GTCR. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GTCR makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Surmodics?
Surmodics was acquired by GTCR, based in Chicago. The deal was reported on April 28, 2025. GTCR is a leading private equity firm focused on investing in growth and could manage companies. They specialize in various sectors including financial services and technology. GTCR is privately held and operates in Financial Services.
When did GTCR acquire Surmodics?
GTCR's acquisition of Surmodics was reported on April 28, 2025. Surmodics, Inc. has announced that it will not host a live webcast for its Q2 2025 financial results due to a pending acquisition by GTCR. The financial results will be released on April 30, 2025. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Surmodics do?
Surmodics is a leading provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It is privately held, operating in Manufacturing, and is based in Eden Prairie.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.